Teva Pharmaceutical Industries (TEVA) EBIT Growth (5y) (2014 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBIT Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.11% |
| Mar 31, 2026 | 8.48% |
| Dec 31, 2025 | -5.87% |
| Sep 30, 2025 | 17.11% |
| Jun 30, 2025 | 21.34% |
| Mar 31, 2025 | 22.13% |
| Dec 31, 2024 | -17.04% |
| Sep 30, 2024 | 8.84% |
| Jun 30, 2024 | 62.15% |
| Mar 31, 2024 | -29.39% |
| Dec 31, 2023 | 17.49% |
| Sep 30, 2023 | 84.71% |
| Jun 30, 2023 | -115.72% |
| Mar 31, 2023 | -14.97% |
| Dec 31, 2022 | 40.88% |
| Sep 30, 2022 | 2.32% |
| Jun 30, 2022 | 29.97% |
| Mar 31, 2022 | -22.84% |
| Dec 31, 2021 | 20.77% |
| Sep 30, 2021 | -4.02% |